News Sentiment

DNA sentiment intelligence

Ginkgo Bioworks Holdings news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 65 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 7.91 Week of 17 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

78/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-13.0% over one week, -13.7% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 78/100 classification
One-week reaction -13.0% Price reacting lower
Trend fit Trend active -13.7% over four weeks
Fair value -66.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 50
Negative 10

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 18
Market source 10
simplywall.st 5
Sahm 4
TradingView 4
PR Newswire 3
Stock Traders Daily 2
The Globe and Mail 1

Event Lens

What the news is about

Classified themes
Market update 33
Earnings 24
Regulatory and legal 3
Balance sheet 2
Guidance 1
Analyst action 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 65
Sahm Direct company coverage

Ginkgo Bioworks Holdings (DNA) TTM Net Loss Of US$312.8 Million Reinforces Bearish Narratives

Ginkgo Bioworks Holdings (DNA) reported a TTM net loss of US$312.8 million for FY 2025, with revenue declining from US$227.0 million to US$170.2 million. The company's EPS loss narrowed, but it is expected to remain unprofitable for at least three more years. Despite ongoing loss

Tone
Negative 18/100
Event
Earnings
Published
09 May 2026 13:09
Source
Sahm
Stock Titan Direct company coverage

Ginkgo Bioworks (NYSE: DNA) posts Q1 2026 loss and exits Biosecurity unit

Ginkgo Bioworks (NYSE: DNA) reported a Q1 2026 net loss of $82.6 million, with revenue from continuing operations at $19.5 million. The company completed the strategic divestiture of its Biosecurity unit in April 2026, transferring operations in exchange for an approximate 20% eq

Tone
Neutral 50/100
Event
Earnings
Published
08 May 2026 01:39
Source
Stock Titan
Stock Titan Direct company coverage

DNA SEC Filings - Ginkgo Bioworks Holdings Inc 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for investors to access Ginkgo Bioworks Holdings Inc. (NYSE: DNA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider trading forms. Recent 8-K filings cover financial results, stock offe

Tone
Neutral 50/100
Event
Earnings
Published
04 May 2026 11:39
Source
Stock Titan
Morningstar Direct company coverage

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) announced that it will host a presentation and Q&A session to review its business performance for the first quarter ended March 31, 2026. This session is scheduled for Thursday, May 7, 2026, at 4:30 p.m. ET. Presentation details and a we

Tone
Neutral 50/100
Event
Earnings
Published
30 Apr 2026 12:01
Source
Morningstar
Sahm Direct company coverage

Will Ginkgo Bioworks Holdings (NYSE:DNA) Spend Its Cash Wisely?

Ginkgo Bioworks Holdings (NYSE:DNA) currently has a cash runway of about 2.4 years based on its US$423m cash reserves and US$179m annual cash burn. While the company reduced its cash burn by 53% last year, revenue also dipped by 25%. Raising more capital could lead to significant

Tone
Neutral 50/100
Event
Balance sheet
Published
30 Apr 2026 09:10
Source
Sahm
Stock Titan Direct company coverage

Ginkgo Bioworks (NYSE: DNA) sets 2026 virtual meeting, auditor and pay votes

Ginkgo Bioworks will hold its virtual 2026 annual shareholder meeting on June 11, 2026, where shareholders will vote on the election of six directors, the ratification of Deloitte & Touche LLP as the independent auditor for 2026, and an advisory vote on executive compensation. Th

Tone
Neutral 50/100
Event
Market update
Published
29 Apr 2026 20:39
Source
Stock Titan
Investing.com South Africa Direct company coverage

Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares By Investing.com

Ginkgo Bioworks CFO Steven Coen sold 324 shares of the company's Class A Common Stock for approximately $2,576. This transaction was primarily to cover tax withholding obligations related to the vesting of restricted stock and not a discretionary trade. The sale occurred after Mr

Tone
Neutral 50/100
Event
Market update
Published
20 Apr 2026 23:24
Source
Investing.com South Africa
Investing.com Direct company coverage

Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares

Ginkgo Bioworks CFO Steven Coen sold 324 shares of Class A Common Stock for approximately $2,576 to cover tax withholding obligations. This transaction followed his acquisition of 743 shares through RSU vesting on April 16, 2026, bringing his direct holdings to 50,268 shares. The

Tone
Neutral 50/100
Event
Deals and strategy
Published
20 Apr 2026 21:39
Source
Investing.com